{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:27:00Z","timestamp":1787660820891,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biologicals.2026.101906","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:56:14Z","timestamp":1786049774000},"page":"101906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a novel competitive ELISA method for Typhoid Vi Polysaccharide Quantitation"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9812-2854","authenticated-orcid":false,"given":"Ashwani Kumar","family":"Mandyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1037-3316","authenticated-orcid":false,"given":"Rajasekaran","family":"Angannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0111-8245","authenticated-orcid":false,"given":"Balananda Dhurjati Kumar","family":"Putcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8130-5396","authenticated-orcid":false,"given":"Charles","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6585-7079","authenticated-orcid":false,"given":"Tarun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2026.101906_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15585\/mmwr.mm7207a2","article-title":"Typhoid fever surveillance, incidence estimates, and progress toward typhoid conjugate vaccine introduction - worldwide, 2018-2022","volume":"72","author":"Hancuh","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.biologicals.2026.101906_bib2","first-page":"1","article-title":"Kwon SY and other 11 authors, immune persistence after 5 years of vaccination by Vi-DT vaccine among children below 2 years: result from long-term observational study","volume":"11","author":"Pial","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2026.101906_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2025.2507912","article-title":"Comparative immune response of typbar TCV\u00ae (typhoid conjugate vaccine) in extremes of age: an Indian experience","volume":"21","author":"Vadrevu","year":"2025","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2026.101906_bib4","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2021.07.073","article-title":"Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV\u00ae) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination","volume":"39","author":"Vadrevu","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2026.101906_bib5","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1021\/acs.analchem.9b05107","article-title":"Development of a specific and sensitive HPAEC-PAD method for quantification of vi polysaccharide applicable to other polysaccharides containing amino uronic acids","volume":"92","author":"Giannelli","year":"2020","journal-title":"Anal Chem"},{"issue":"Suppl2","key":"10.1016\/j.biologicals.2026.101906_bib6","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/cid\/ciaa504","article-title":"Review on the recent advances on typhoid vaccine development and challenges ahead","volume":"71","author":"Syed","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.biologicals.2026.101906_bib7","first-page":"1","article-title":"Validation of an inhibition-type ELISA to quantify Vi polysaccharide in the Cuban antityphoid vaccine vax-TyVi\u00e2\u00e2","volume":"15","author":"Fajardo","year":"2006","journal-title":"VacciMonitor"},{"key":"10.1016\/j.biologicals.2026.101906_bib8","first-page":"190","article-title":"Quantification of polysaccharide Vi in the typhoid vaccine VaxTyViTM by sandwich ELISA using a monoclonal antibody","volume":"1","author":"Bencomo","year":"2016","journal-title":"Bionatura"},{"key":"10.1016\/j.biologicals.2026.101906_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2026.101906_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113043","article-title":"Sensitive quantitation of low level free polysaccharide in conjugate vaccines by size exclusion chromatography-reverse phase liquid chromatography with UV detection","volume":"180","author":"Schuchmann","year":"2020","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"3","key":"10.1016\/j.biologicals.2026.101906_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/CVI.00354-09","article-title":"Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar typhi Vi polysaccharide","volume":"17","author":"Staats","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"39","key":"10.1016\/j.biologicals.2026.101906_bib12","doi-asserted-by":"crossref","first-page":"24443","DOI":"10.1073\/pnas.2005857117","article-title":"Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine","volume":"117","author":"Micoli","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.biologicals.2026.101906_bib13","series-title":"Monograph in: indian pharmacopoeia","first-page":"42","article-title":"Vaccines and immunosera for human use","year":"2022"},{"key":"10.1016\/j.biologicals.2026.101906_bib14","series-title":"WHO expert committee on biological standardization. Evaluation of candidate international standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi","author":"Gao","year":"2017"},{"key":"10.1016\/j.biologicals.2026.101906_bib15","first-page":"259","article-title":"Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines","volume":"103","author":"Lei","year":"2000","journal-title":"Dev Biologicals"},{"key":"10.1016\/j.biologicals.2026.101906_bib16","series-title":"WHO international standard 1st IS for anti-typhoid capsular Vi polysaccharide IgG (human), NIBSC code: 16\/138. Instructions for use, version 5.0","year":"2024"},{"issue":"1","key":"10.1016\/j.biologicals.2026.101906_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/bc00031a015","article-title":"Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media","volume":"6","author":"Nakajima","year":"1995","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biologicals.2026.101906_bib18","series-title":"Bioconjugate techniques","author":"Hermanson","year":"2013"},{"key":"10.1016\/j.biologicals.2026.101906_bib19","series-title":"Thermo fisher Scientific, EZ LinkTM sulfo NHS-LC-LC-Biotin instructions manual","year":"2016"},{"key":"10.1016\/j.biologicals.2026.101906_bib20","series-title":"Guidelines on bioanalytical method validation. EMEA\/CHMP\/EWP\/192217\/21009 Rev.1Corr. 2","year":"2011"},{"key":"10.1016\/j.biologicals.2026.101906_bib21","series-title":"Bioanalytical method validation and study sample analysis M-10","year":"2022"},{"key":"10.1016\/j.biologicals.2026.101906_bib22","series-title":"International standard for Vi polysaccharide of S. typhi, NIBSC code: 16\/126. Instructions for use, version 6.0","year":"2021"},{"key":"10.1016\/j.biologicals.2026.101906_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cropro.2017.07.019","article-title":"Bland-altman comparison of two methods for assessing severity of verticillium wilt of potato","volume":"101","author":"Yellareddygari","year":"2017","journal-title":"Crop Prot"},{"key":"10.1016\/j.biologicals.2026.101906_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007912","article-title":"A phase 1 randomized safety, reactogenicity, and immunogenicity study of typhax: a novel protein capsular matrix vaccine candidate for the prevention of typhoid fever","volume":"14","author":"Cartee","year":"2020","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.biologicals.2026.101906_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2301631","article-title":"Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers","volume":"20","author":"Tamrakar","year":"2024","journal-title":"Hum Vaccines Immunother"},{"issue":"1707","key":"10.1016\/j.biologicals.2026.101906_bib26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3390\/microorganisms9081707","article-title":"Evidence of extended thermo-stability of typhoid polysaccharide conjugate vaccines","volume":"9","author":"Gao","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.biologicals.2026.101906_bib27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.vaccine.2011.12.046","article-title":"Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine","volume":"30","author":"An","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2026.101906_bib28","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1016\/j.vaccine.2013.08.037","article-title":"A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi","volume":"31","author":"Kothari","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2026.101906_bib29","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"330","author":"Klugman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2026.101906_bib30","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/archinte.1995.00430210041007","article-title":"A new typhoid vaccine composed of the Vi capsular polysaccharide","volume":"155","author":"Plotkin","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.biologicals.2026.101906_bib31","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/iai.59.12.4555-4561.1991","article-title":"Relation between structure and immunologic properties of the Vi capsular polysaccharide","volume":"159","author":"Szu","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2026.101906_bib32","series-title":"WHO expert committee on biological standardization. Forty-third report","article-title":"Requirements for Vi polysaccharide typhoid vaccine (requirements for biological substances no. 48), pp14-30","year":"1994"},{"key":"10.1016\/j.biologicals.2026.101906_bib33","series-title":"WHO expert committee on biological standardization, 64th report","first-page":"103","article-title":"Guidelines on the quality, safety and efficacy of typhoid conjugate vaccines","year":"2014"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:08:13Z","timestamp":1787659693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105626000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S1045105626000345"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101906","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel competitive ELISA method for Typhoid Vi Polysaccharide Quantitation","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101906"}}